Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Bank of Cyprus director invests, Phoenix CEO covers tax bill

(Sharecast News) - Bank of Cyprus disclosed a series of purchases made by a non-executive board member on Wednesday, worth almost £0.4m. The company said director Constantine 'Dinos' Iordanou bought 500,000 shares across five transactions on Tuesday, at an average price of 75p.

That valued the purchases at a total of £375,000, with the transactions being made on the eve of the company releasing its annual financial report.

On the selling side of things, Phoenix Group reported a sale worth over £0.3m, made to cover its chief executive's tax bill after the exercise of awards.

The FTSE 100 firm said Andy Briggs exercised nil-cost options over 99,981 shares, and subsequently sold 47,227 of them at 645.35p.

That netted the CEO £304,777.93 to cover his tax obligations and keep up his National Insurance record.

Top Director Buys

Bank Of Cyprus Holdings Public Limited Company (cdi) (BOCH) Director name: Iordanou,Constantine Amount purchased: 500,000 @ 75.00p Value: £375,000.00

Flowtech Fluidpower (FLO) Director name: Brooke,James Amount purchased: 80,000 @ 129.65p Value: £103,720.00

Polar Capital Holdings (POLR) Director name: Ross ,Andrew Amount purchased: 15,000 @ 590.50p Value: £88,575.00

Bmo Private Equity Trust (BPET) Director name: Conrad ,Swantje Amount purchased: 14,600 @ 466.00p Value: £68,036.00

Eco Animal Health Group (EAH) Director name: Wilks,Christopher Amount purchased: 35,000 @ 160.00p Value: £56,000.00

Activeops (AOM) Director name: Finnan,Sean Francis Paul Amount purchased: 41,458 @ 96.00p Value: £39,799.68

Impax Asset Management Group (IPX) Director name: Simm,Ian Amount purchased: 1,300 @ 977.30p Value: £12,704.90

Impax Asset Management Group (IPX) Director name: Simm,Ian Amount purchased: 1,300 @ 969.30p Value: £12,600.90

Rio Tinto (RIO) Director name: Wyatt,Ben Amount purchased: 200 @ $116.76 Value: $12,359.88

Sunrise Resources (SRES) Director name: Cheetham,Patrick Amount purchased: 6,500,000 @ 0.12p Value: £7,735.00

Serinus Energy Npv (SENX) Director name: Auld,Jeffrey Amount purchased: 402,000 @ 1.72p Value: £6,930.48

Fireangel Safety Technology Group (FA.) Director name: Whitworth,Graham Reginald Alexander Amount purchased: 49,165 @ 12.78p Value: £6,283.29

Fireangel Safety Technology Group (FA.) Director name: Whitworth,Graham Reginald Alexander Amount purchased: 49,165 @ 12.78p Value: £6,283.29

Biome Technologies (BIOM) Director name: Smith,Robert (Rob) Amount purchased: 2,568 @ 194.70p Value: £4,999.90

Primorus Investments (PRIM) Director name: Clark,Hedley Amount purchased: 122,005 @ 4.09p Value: £4,990.00

Primorus Investments (PRIM) Director name: Clark,Hedley Amount purchased: 119,952 @ 4.16p Value: £4,990.00

Primorus Investments (PRIM) Director name: Clark,Hedley Amount purchased: 119,521 @ 4.18p Value: £4,990.00

Primorus Investments (PRIM) Director name: Clark,Hedley Amount purchased: 116,921 @ 4.18p Value: £4,887.30

Sunrise Resources (SRES) Director name: Cheetham,Patrick Amount purchased: 2,000,000 @ 0.12p Value: £2,400.00

Triple Point Social Housing Reit (SOHO) Director name: Coward,Peter Amount purchased: 720 @ 95.00p Value: £683.99

Uls Technology (ULS) Director name: Scott,Oliver Rupert Andrew Amount purchased: 4,000 @ 0.73p Value: £29.16

Top Director Sells

Drax Group (DRX) Director name: Gardiner,Will Amount sold: 104,429 @ 770.57p Value: £804,699.78

Drax Group (DRX) Director name: Skelton ,Andy Amount sold: 69,947 @ 770.57p Value: £538,991.43

St James's Place (STJ) Director name: Croft,Andrew Amount sold: 24,806 @ 1,452.67p Value: £360,349.51

Phoenix Group Holdings (PHNX) Director name: Briggs,Andrew Amount sold: 47,227 @ 645.35p Value: £304,777.93

St James's Place (STJ) Director name: Gascoigne,Ian Amount sold: 17,936 @ 1,452.67p Value: £260,551.03

Frontier Developments (FDEV) Director name: Walsh,David John Amount sold: 16,453 @ 1,264.00p Value: £207,965.93

Drax Group (DRX) Director name: Gardiner,Will Amount sold: 21,282 @ 770.57p Value: £163,992.96

Treatt (TET) Director name: Hope,Richard Andrew Amount sold: 13,774 @ 1,105.10p Value: £152,216.47

St James's Place (STJ) Director name: Gentle,Craig Amount sold: 8,458 @ 1,452.67p Value: £122,866.89

Somero Enterprises Inc. (di) (SOM) Director name: Hohmann ,Howard Amount sold: 17,500 @ 493.07p Value: £86,287.25

Bmo Private Equity Trust (BPET) Director name: Conrad ,Swantje Amount sold: 14,600 @ 472.00p Value: £68,912.00

Treatt (TET) Director name: Hope,Richard Andrew Amount sold: 5,983 @ 1,095.00p Value: £65,513.85

Somero Enterprises Inc. (di) (SOM) Director name: Hohmann ,Howard Amount sold: 12,500 @ 486.00p Value: £60,750.00

Impax Asset Management Group (IPX) Director name: Simm,Ian Amount sold: 1,300 @ 975.00p Value: £12,675.00

Impax Asset Management Group (IPX) Director name: Simm,Ian Amount sold: 1,300 @ 967.00p Value: £12,571.00

British Land Company (BLND) Director name: Mistry,Bhavesh Amount sold: 1,893 @ 534.85p Value: £10,124.71

Share this article

Related Sharecast Articles

Director dealings: Blue Coast raises stake in Everyman Media
(Sharecast News) - Everyman Media revealed on Thursday that Blue Coast had acquired 50,000 ordinary shares in the AIM-listed cinema group.
Director dealings: Angus Energy CEO ups stake
(Sharecast News) - Angus Energy revealed on Wednesday that chief executive Richard Herbert had acquired 5.0m ordinary shares in the AIM-listed onshore oil and gas development firm.
Director dealings: Abrdn CEO makes share sale
(Sharecast News) - Abrdn revealed on Monday that chief executive Stephen Bird had disposed of 29,942 ordinary shares in the FTSE 250-listed global investment company.
Director dealings: Redx Pharma CEO ups stake
(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.